C284H238F3N18O3P8Pt8+5 — CID 157419959
(3-tert-butyl-5-diphenylphosphorylbenzene-6-id-1-yl)-diphenylmethanol;2-(3-tert-butyl-5-pyrazol-2-id-3-ylbenzene-6-id-1-yl)pyridine;4-(3-tert-butyl-5-pyrazol-1-ylbenzene-6-id-1-yl)-5-(trifluoromethyl)imidazol-3-ide;2-(9-methanidylfluoren-9-yl)-6-phenylpyridine;2-(5-methylimidazol-3-id-4-yl)-6-phenylpyridine;2-phenyl-6-pyrrol-1-id-2-ylpyridine;2-phenylquinolin-8-ol;platinum;hexakis(platinum(2+));pyridine;1-(3-pyrrol-1-id-2-ylbenzene-2-id-1-yl)pyrazole;heptakis(triphenylphosphanium) (PubChem CID 157419959) has the molecular formula C284H238F3N18O3P8Pt8+5 and a molecular weight of 5816.56 g/mol. Its IUPAC name is (3-tert-butyl-5-diphenylphosphorylbenzene-6-id-1-yl)-diphenylmethanol;2-(3-tert-butyl-5-pyrazol-2-id-3-ylbenzene-6-id-1-yl)pyridine;4-(3-tert-butyl-5-pyrazol-1-ylbenzene-6-id-1-yl)-5-(trifluoromethyl)imidazol-3-ide;2-(9-methanidylfluoren-9-yl)-6-phenylpyridine;2-(5-methylimidazol-3-id-4-yl)-6-phenylpyridine;2-phenyl-6-pyrrol-1-id-2-ylpyridine;2-phenylquinolin-8-ol;platinum;hexakis(platinum(2+));pyridine;1-(3-pyrrol-1-id-2-ylbenzene-2-id-1-yl)pyrazole;heptakis(triphenylphosphanium).
| Compound Name | (3-tert-butyl-5-diphenylphosphorylbenzene-6-id-1-yl)-diphenylmethanol;2-(3-tert-butyl-5-pyrazol-2-id-3-ylbenzene-6-id-1-yl)pyridine;4-(3-tert-butyl-5-pyrazol-1-ylbenzene-6-id-1-yl)-5-(trifluoromethyl)imidazol-3-ide;2-(9-methanidylfluoren-9-yl)-6-phenylpyridine;2-(5-methylimidazol-3-id-4-yl)-6-phenylpyridine;2-phenyl-6-pyrrol-1-id-2-ylpyridine;2-phenylquinolin-8-ol;platinum;hexakis(platinum(2+));pyridine;1-(3-pyrrol-1-id-2-ylbenzene-2-id-1-yl)pyrazole;heptakis(triphenylphosphanium) |
|---|---|
| PubChem CID | 157419959 |
| Molecular Formula | C284H238F3N18O3P8Pt8+5 |
| Molecular Weight | 5816.56 g/mol |
| Exact Mass | 5812.40 |
| IUPAC Name | (3-tert-butyl-5-diphenylphosphorylbenzene-6-id-1-yl)-diphenylmethanol;2-(3-tert-butyl-5-pyrazol-2-id-3-ylbenzene-6-id-1-yl)pyridine;4-(3-tert-butyl-5-pyrazol-1-ylbenzene-6-id-1-yl)-5-(trifluoromethyl)imidazol-3-ide;2-(9-methanidylfluoren-9-yl)-6-phenylpyridine;2-(5-methylimidazol-3-id-4-yl)-6-phenylpyridine;2-phenyl-6-pyrrol-1-id-2-ylpyridine;2-phenylquinolin-8-ol;platinum;hexakis(platinum(2+));pyridine;1-(3-pyrrol-1-id-2-ylbenzene-2-id-1-yl)pyrazole;heptakis(triphenylphosphanium) |
| SMILES | CC(C)(C)c1cc(-c2[n-]cnc2C(F)(F)F)[c-]c(-n2cccn2)c1.CC(C)(C)c1cc(-c2ccccn2)[c-]c(-c2ccn[n-]2)c1.CC(C)(C)c1cc(C(O)(c2ccccc2)c2ccccc2)[c-]c(P(=O)(c2ccccc2)c2ccccc2)c1.Cc1nc[n-]c1-c1cccc(-c2[c-]cccc2)n1.Oc1cccc2ccc(-c3[c-]cccc3)nc12.[CH2-]C1(c2cccc(-c3[c-]cccc3)n2)c2ccccc2-c2ccccc21.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt].[Pt].[c-]1c(-c2ccc[n-]2)cccc1-n1cccn1.[c-]1ccccc1-c1cccc(-c2ccc[n-]2)n1.c1ccc([PH+](c2ccccc2)c2ccccc2)cc1.c1ccc([PH+](c2ccccc2)c2ccccc2)cc1.c1ccc([PH+](c2ccccc2)c2ccccc2)cc1.c1ccc([PH+](c2ccccc2)c2ccccc2)cc1.c1ccc([PH+](c2ccccc2)c2ccccc2)cc1.c1ccc([PH+](c2ccccc2)c2ccccc2)cc1.c1ccc([PH+](c2ccccc2)c2ccccc2)cc1.c1ccncc1 |
| InChI | InChI=1S/C35H32O2P.C25H17N.C18H17N3.7C18H15P.C17H15F3N4.C15H11N3.C15H10N2.C15H10NO.C13H9N3.C5H5N.8Pt/c1-34(2,3)29-24-30(35(36,27-16-8-4-9-17-27)28-18-10-5-11-19-28)26-33(25-29)38(37,31-20-12-6-13-21-31)32-22-14-7-15-23-32;1-25(24-17-9-16-23(26-24)18-10-3-2-4-11-18)21-14-7-5-12-19(21)20-13-6-8-15-22(20)25;1-18(2,3)15-11-13(16-6-4-5-8-19-16)10-14(12-15)17-7-9-20-21-17;7*1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;1-16(2,3)12-7-11(8-13(9-12)24-6-4-5-23-24)14-15(17(18,19)20)22-10-21-14;1-11-15(17-10-16-11)14-9-5-8-13(18-14)12-6-3-2-4-7-12;1-2-6-12(7-3-1)13-8-4-9-15(17-13)14-10-5-11-16-14;17-14-8-4-7-12-9-10-13(16-15(12)14)11-5-2-1-3-6-11;1-4-11(13-6-2-7-14-13)10-12(5-1)16-9-3-8-15-16;1-2-4-6-5-3-1;;;;;;;;/h4-25,36H,1-3H3;2-10,12-17H,1H2;4-9,11-12H,1-3H3;7*1-15H;4-7,9-10H,1-3H3;2-6,8-10H,1H3;1-6,8-11H;1-5,7-10,17H;1-9H;1-5H;;;;;;;;/q-1;2*-2;;;;;;;;3*-2;-1;-2;;;;6*+2/p+7 |
| InChIKey | PCEZQUUXFOLKKV-UHFFFAOYSA-U |
| XLogP | 55.33 |
| TPSA | 279.68 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 40 |
| Heavy Atoms | 324 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 5816.56 |
| LogP ≤ 5 | 55.33 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 16 |